Yongkun Sun

机构：Xuzhou University of Technology, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, Yinchuan First People's Hospital, National Cancer Center · ORCID：0000-0003-3302-6023

发表论文 137 篇 · 总被引 2514 次 · h-index 22

代表论文

• Perioperative chemotherapy with docetaxel plus oxaliplatin and S-1 (DOS) versus oxaliplatin plus S-1 (SOX) for the treatment of locally advanced gastric or gastro-esophageal junction adenocarcinoma (MATCH): an open-label, randomized, phase 2 clinical trial (2024 · Gastric Cancer · 被引 22)
• Consensus of Chinese Experts on Neoadjuvant and Conversion Therapies for Hepatocellular Carcinoma: 2023 Update (2024 · Liver Cancer · 被引 18)
• Trilayered biomimetic hydrogel scaffolds with dual-differential microenvironment for articular osteochondral defect repair (2024 · Materials Today Bio · 被引 17)
• A single-arm, multicenter, phase 2 clinical study of recombinant humanized anti-HER2 monoclonal antibody-MMAE conjugate (MRG002) in HER2-positive unresectable locally advanced or metastatic urothelial carcinoma (2024 · European Journal of Cancer · 被引 11)
• Phase II Study of Irinotecan, Trifluridine/tipiracil (TAS-102) plus Bevacizumab as a Later-line Therapy for Patients with Metastatic Colorectal Cancer (mCRC): a prospective single-center explorative study (2024 · British Journal of Cancer · 被引 7)
• Transforming “cold” tumors into “hot” ones via immunogenic cell death by bufadienolides for reverse immunosuppressive TME in HCC (2025 · Journal of Materials Chemistry B · 被引 6)